A Double-Blind Randomized Phase I Clinical Trial Targeting ALVAC-HIV Vaccine to Human Dendritic Cells

PLoS ONE - United States
doi 10.1371/journal.pone.0024254
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Lidocaine for Systemic Sclerosis: A Double-Blind Randomized Clinical Trial

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2011English

Double-Blind, Randomized, Controlled Clinical Trial of Norfloxacin for Cholera.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1990English

Chocolate Flavanols and Skin Photoprotection: A Parallel, Double-Blind, Randomized Clinical Trial

Nutrition Journal
MedicineNutritionDietetics
2014English

Laser Assisted Non-Surgical Periodontal Therapy: A Double Blind, Randomized Clinical Trial

Open Dentistry Journal
Dentistry
2017English

Safety, Tolerability, and Pharmacokinetics of Adrenomedullin in Healthy Males: A Randomized, Double-Blind, Phase 1 Clinical Trial

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2020English

Targeting Dendritic Cells: A Promising Strategy to Improve Vaccine Effectiveness

Clinical and Translational Immunology
AllergyImmunologyNursing
2016English

Etanercept in Alzheimer Disease: A Randomized, Placebo-Controlled, Double-Blind, Phase 2 Trial

Neurology
Neurology
2015English

A Randomized Double Blind Clinical Trial on a Sabgh Formulation for Patients With Vitiligo

Journal of Evidence-Based Complementary & Alternative Medicine
2015English

Fish‐Skin Grafts Compared to Human Amnion/Chorion Membrane Allografts: A Double‐Blind, Prospective, Randomized, Clinical Trial of Acute Wound Healing

Wound Repair and Regeneration
DermatologySurgery
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy